Al­ta­sciences, true to its word, ex­pands its foot­print with ac­qui­si­tion of Penn­syl­va­nia CRO

A Cana­di­an CD­MO with roots in Seat­tle is com­ing to the east coast.

Al­ta­sciences an­nounced the ac­qui­si­tion of Calvert Lab­o­ra­to­ries Wednes­day, a pre­clin­i­cal CRO in Penn­syl­va­nia. The move will com­ple­ment Al­ta­sciences’ Seat­tle-area op­er­a­tions.

Head­quar­tered in Laval, Cana­da, Al­ta­sciences op­er­ates six fa­cil­i­ties that run the gamut on ear­ly drug de­vel­op­ment: pre­clin­i­cal safe­ty test­ing, clin­i­cal phar­ma­col­o­gy, bio­an­a­lyt­i­cal, CRO ser­vices, and even CD­MO ca­pac­i­ty. No­vo Hold­ings scooped them up in Feb­ru­ary with the goal of court­ing small and medi­um-sized bio­phar­ma clients. CEO Chris Perkin said back in Feb­ru­ary that the move would help the com­pa­ny fos­ter its am­bi­tious growth plan, and this ac­qui­si­tion and the pres­ence it brings to the east coast is ev­i­dence.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER